2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI？是时候来Springer出书了！ |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | LUNG CANCER LUNG CANCER （此期刊被最新的JCR期刊SCIE收录） LetPub评分 7.8
56人评分
我要评分
声誉 8.8 影响力 6.8 速度 8.8 | |||||||||||||||||||||||||
| 期刊ISSN | 0169-5002 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||
| E-ISSN | 1872-8332 | |||||||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：5.14 | |||||||||||||||||||||||||
| 2025-2026自引率 | 3.8%点击查看自引率趋势图 | |||||||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 5.102数据由网友[樱花4131]收集提供 | |||||||||||||||||||||||||
| h-index | 114 | |||||||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||
| 期刊官方网站 | http://www.journals.elsevier.com/lung-cancer/ | |||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/LUNGCANCER | |||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Vebreltinib plus EGFR-TKI for EGFR-mutated NSCLC with MET-driven resistance: A real-world study of Chinese patients Author: Wang, Haibo; Cai, Yanyu; Jiang, Kan; Zou, Wei; Xiao, Weijin; Xu, Haipeng; Huang, Yunjian; He, Zhiyong; Xu, Yiquan; Huang, Zhangzhou Journal: LUNG CANCER. 2026; Vol. 217, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109412 A dynamic proteomic signature for the prediction of lung Cancer: a longitudinal analysis in the UK Biobank cohort Author: Liang, Jie; Feng, Yi; Gui, Daying; Zheng, Xiangyuan; Gao, Rui; Zhou, Jingdong; Liang, Jiekai; Diao, Jingwen; He, Juan; Zhao, Yilin; He, Jianxing; Wu, Xuan; Cheng, Bo; Liang, Wenhua Journal: LUNG CANCER. 2026; Vol. 217, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109424 Clinical outcomes and tumor immune microenvironment in SMARCA4-Deficient NSCLC: A Real-World retrospective study Author: Zhao, Wencheng; Guan, Maoying; Zhang, Huixian; Chen, Xuyang; Huang, Runze; Zhang, Wengang; Liu, Xinyue; Li, Yujie; Wang, Hao; Zhao, Lishu; Xu, Kandi; Ye, Li; Chen, Zhimin; He, Yayi Journal: LUNG CANCER. 2026; Vol. 217, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109414 SMARCA4-deficient thoracic tumors exhibit an immunosuppressive microenvironment and respond to combined antiangiogenic and immune checkpoint inhibitor therapy Author: Zhang, Panpan; Kuang, Yanbin; Jia, Bo; Tian, Zhihua; Deng, Mi; Nie, Jun; Dai, Ling; Dong, Bin; Yang, Xin; Long, Mengping; Liu, Bing; Zhang, Jie; Wu, Di; Ma, Xiangjuan; Chen, Xiaoling; Tian, Guangming; Han, Sen; Long, Jieran; Zhang, Ziran; Han, Jindi; Hao, Qianyun; Ji, Xumeng; Liu, Beibei; Wang, Hua; Hu, Weiheng; Wang, Ziping; Fang, Jian Journal: LUNG CANCER. 2026; Vol. 217, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109417 | |||||||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足LUNG CANCER的语言要求，还能让LUNG CANCER编辑和审稿人得到更好的审稿体验，让稿件最大限度地被LUNG CANCER编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢（2篇） 。 提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||
| 通讯方式 | ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, IRELAND, 00000 | |||||||||||||||||||||||||
| 出版商 | Elsevier Ireland Ltd | |||||||||||||||||||||||||
| 涉及的研究方向 | 医学-呼吸系统 | |||||||||||||||||||||||||
| 出版国家或地区 | NETHERLANDS | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||
| 出版年份 | 1985 | |||||||||||||||||||||||||
| 年文章数 | 320点击查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 30.75% | |||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 91.88% | |||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||
  | ||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0169-5002%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 一般,3-6周 来源Elsevier官网： 平均5.9周 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较难 | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在LUNG CANCER顺利发表。
快看看作者怎么说吧：服务好评 论文致谢（2篇） 。 提交文稿 | |||||||||||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均3.1周 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Vebreltinib plus EGFR-TKI for EGFR-mutated NSCLC with MET-driven resistance: A real-world study of Chinese patients Author: Wang, Haibo; Cai, Yanyu; Jiang, Kan; Zou, Wei; Xiao, Weijin; Xu, Haipeng; Huang, Yunjian; He, Zhiyong; Xu, Yiquan; Huang, Zhangzhou Journal: LUNG CANCER. 2026; Vol. 217, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109412 PubMed DOI |
| 2. | A dynamic proteomic signature for the prediction of lung Cancer: a longitudinal analysis in the UK Biobank cohort Author: Liang, Jie; Feng, Yi; Gui, Daying; Zheng, Xiangyuan; Gao, Rui; Zhou, Jingdong; Liang, Jiekai; Diao, Jingwen; He, Juan; Zhao, Yilin; He, Jianxing; Wu, Xuan; Cheng, Bo; Liang, Wenhua Journal: LUNG CANCER. 2026; Vol. 217, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109424 PubMed DOI |
| 3. | Clinical outcomes and tumor immune microenvironment in SMARCA4-Deficient NSCLC: A Real-World retrospective study Author: Zhao, Wencheng; Guan, Maoying; Zhang, Huixian; Chen, Xuyang; Huang, Runze; Zhang, Wengang; Liu, Xinyue; Li, Yujie; Wang, Hao; Zhao, Lishu; Xu, Kandi; Ye, Li; Chen, Zhimin; He, Yayi Journal: LUNG CANCER. 2026; Vol. 217, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109414 PubMed DOI |
| 4. | SMARCA4-deficient thoracic tumors exhibit an immunosuppressive microenvironment and respond to combined antiangiogenic and immune checkpoint inhibitor therapy Author: Zhang, Panpan; Kuang, Yanbin; Jia, Bo; Tian, Zhihua; Deng, Mi; Nie, Jun; Dai, Ling; Dong, Bin; Yang, Xin; Long, Mengping; Liu, Bing; Zhang, Jie; Wu, Di; Ma, Xiangjuan; Chen, Xiaoling; Tian, Guangming; Han, Sen; Long, Jieran; Zhang, Ziran; Han, Jindi; Hao, Qianyun; Ji, Xumeng; Liu, Beibei; Wang, Hua; Hu, Weiheng; Wang, Ziping; Fang, Jian Journal: LUNG CANCER. 2026; Vol. 217, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109417 PubMed DOI |
| 5. | Treatment patterns of elderly patients with limited-stage small-cell lung cancer in real-world data: A multicentre retrospective analysis Author: Sun, Zhuoran; Xin, Weikang; Tian, Yaru; Lu, Shuangqing; Wang, Yujie; Li, Li; Han, Shuting; Tang, Xiaoyong; Zhu, Hui Journal: LUNG CANCER. 2026; Vol. 217, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109450 PubMed DOI |
| 6. | DNA methylation biomarkers-based method for the differential diagnosis of multiple lung cancers Author: Xu, Ke; Tan, Binghua; Liang, Ruihao; Liang, Jialu; He, Zhanghai; He, Jianqun; Zhong, Yiming; Hu, Xueting; Lei, Kai; Lu, Hanlin; Zhang, Juyong; Lin, Huayue; Wang, Minghui Journal: LUNG CANCER. 2026; Vol. 216, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109415 PubMed DOI |
| 7. | Asia-Pacific practical consensus in the management of adverse events related to amivantamab-based therapies in non-small cell lung cancer Author: Soo, Ross A.; Fernandez-Penas, Pablo; Li, Molly; Voon, Pei Jye; Tanizaki, Junko; Tseng, Jeng-Sen; Tan, Chris; Dong, Xiao Rong; Prabhash, Kumar; Kim, Hye Ryun; Hasegawa, Kazuo; Parkinson, Nicole; Kam, Julian; Simoes, Jairo; McGeachie, Marija; Lu, Shun; Pavlakis, Nick Journal: LUNG CANCER. 2026; Vol. 216, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109405 PubMed DOI |
| 8. | Meta-analysis of cutaneous immune-related adverse events in NSCLC: Accounting for treatment heterogeneity and immortal time bias Author: Zhao, Lizheng; Li, Feng; Zhu, Zheqing; Zhao, Jinwei; Zhang, Pengjuan; Ma, Yong; Shen, Fangfang Journal: LUNG CANCER. 2026; Vol. 216, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109422 PubMed DOI |
| 9. | First case report of transformation of adenocarcinoma to adenosquamous carcinoma with giant-cell carcinoma harboring HER2 mutation after zongertinib (BI 1810631) resistance Author: Lin, Jia-Xin; Yin, Kai; Yan, Li-Xu; Zhu, Yue; Xu, Bing-Fei; Sun, Yue-Li; Wu, Yi-Long; Tu, Hai-Yan Journal: LUNG CANCER. 2026; Vol. 216, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.108912 PubMed DOI |
| 10. | Surgery after neoadjuvant immunochemotherapy versus immuno-chemoradiotherapy in patients with cN3 non-small cell lung cancer: A cohort study in two academic centers Author: Zhai, Wenyu; Liang, Dachuan; Yu, Xiangyang; Dai, Shuqin; Guo, Xiaotong; Zhou, Yuheng; Yan, Qihang; Li, Liang; Yang, Jie; Wong, Wingshing; Gong, Li; Duan, Fangfang; Li, Xiaodong; Wang, Junye Journal: LUNG CANCER. 2026; Vol. 216, Issue , pp. -. DOI: 10.1016/j.lungcan.2026.109409 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共133条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
